Literature DB >> 5769742

Procainamide induction of a systemic lupus erythematosus-like syndrome. Presentation of six cases, review of the literature, and analysis and followup of reported cases.

E L Dubois.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5769742

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


× No keyword cloud information.
  18 in total

1.  Clinicopathological study of a patient with procainamide-induced systemic lupus erythematosus.

Authors:  Y Levo; A I Pick; I Avidor; M Ben-Bassat
Journal:  Ann Rheum Dis       Date:  1976-04       Impact factor: 19.103

2.  Procainamide-induced systemic lupus erythematosus.

Authors:  P J Sheldon; W R Williams
Journal:  Ann Rheum Dis       Date:  1970-05       Impact factor: 19.103

3.  Systemic lupus erythematosus during treatment with procainamide.

Authors:  E T Swarbrick; I R Gray
Journal:  Br Heart J       Date:  1972-03

4.  The iceberg analogy of autoimmunity.

Authors:  S Whittingham; I R Mackay
Journal:  Postgrad Med J       Date:  1972-02       Impact factor: 2.401

Review 5.  Is there an ideal antiarrhythmic drug? A review--with particular reference to class I antiarrhythmic agents.

Authors:  K A Muhiddin; P Turner
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

Review 6.  Adverse effects of antiarrhythmic drugs.

Authors:  J B Schwartz; D Keefe; D C Harrison
Journal:  Drugs       Date:  1981-01       Impact factor: 9.546

7.  Occurrence, immunoglobulin pattern and specificity of antinuclear antibodies in sera of procaine amide treated patients.

Authors:  A Klajman; N Camin-Belsky; A Kimchi; S Ben-Efraim
Journal:  Clin Exp Immunol       Date:  1970-11       Impact factor: 4.330

8.  Heterogeneity of anti-mitochondrial antibodies: characterization and separation of the antigen associated with the pseudolupus erythematosus syndrome.

Authors:  T J Sayers; T Binder; P A Berg
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

9.  Efficacy of oral mexiletine in the prevention of exercise-induced ventricular ectopic activity.

Authors:  G Koch; B Lindström
Journal:  Eur J Clin Pharmacol       Date:  1978-06-19       Impact factor: 2.953

10.  Low-dose procainamide: low risk of complications with long-term use.

Authors:  C van Pham; J Noguchi; F P Quismorio; L J Haywood
Journal:  J Natl Med Assoc       Date:  1983-07       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.